Yale School of Public Health Dean Megan L. Ranney, MD, MPH, was honored today as one of 50 individuals and companies driving advances in medicine, fostering innovation, and shaping the future of biopharma and health care.
The honor was bestowed by Fierce Life Sciences and Fierce Healthcare, which named Ranney one of their ‘Fierce 50’ health leaders for 2024. The Fierce family of online publications covers business and policy news in a broad range of health-related industries through such online outlets as Fierce Pharma, Fierce Biotech, Fierce Hospitals, Fierce Health Finance, and others.
Ranney was honored in the ‘Social Impact’ category for her leadership, research, and advocacy in working to prevent firearm injuries.
Read more about Dr. Ranney’s work on firearm injury prevention here.
The Fierce 50 is “a constellation of the most brilliant visionaries and trailblazers, handpicked by the discerning editors of Fierce Biotech, Fierce Pharma and Fierce Healthcare,” the company said in a news release. “These individuals and companies are a driving force in health care delivery, drug development, research, and more.”
Said Ayla Ellison, editor-in-chief of Fierce Life Sciences and Healthcare: “These 50 outstanding organizations and people demonstrate excellence in their fields, and their commitment to innovation, equity, and improving lives is truly commendable. Congratulations to this year’s honorees.”